Janux Therapeutics, Inc. (JANX)
14.03
-0.13
(-0.92%)
USD |
NASDAQ |
Jan 12, 16:00
14.04
+0.02
(+0.11%)
After-Hours: 20:00
Janux Therapeutics Research and Development Expense (Quarterly): 34.63M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| MannKind Corp. | 14.06M |
| Madrigal Pharmaceuticals, Inc. | 173.65M |
| Editas Medicine, Inc. | 19.05M |